Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Would this ruling be considered a material event?

Larry and all, wouldn't this ruling be considered a material event and thus the BOD would be required to convey the news to shareholders and public? It could be in the form of a PR or a SEC filing according to what ever time guidelines are required?

Share
New Message
Please login to post a reply